Qiagen receives approval for its net-zero carbon emissions target by SBTi

QIAGEN announced that its emissions reduction targets have been validated by the Science Based Targets initiative, SBTi, – a global recognition of its ambitions to honor the Paris Agreement’s climate goals. This validation makes QIAGEN one of only a few companies in the pharmaceuticals, life sciences and biotechnology sector with a verified net-zero science-based target. QIAGEN has pledged to hit net-zero greenhouse gas emissions by 2050 from 2020 as the base year. "QIAGEN welcomes the chance to join the group of companies in the world with a verified net-zero target based on science. We believe that it is our moral and strategic responsibility to invest in sustainable business practices. Our stakeholders, including our employees and customers, rightfully expect this from us. We are doing this to help safeguard the environment, but also to ensure the long-term viability of our activities," said Thierry Bernard, CEO of QIAGEN. "We still have a long way to go at QIAGEN in reaching our goals, but we believe that every step is vital in the fight against climate change."